Exploring the genetic factors of hearing loss in Turner Syndrome
Official title: Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome
Run by Gødstrup Hospital · NCT06507007 · Data updated 2026-11-12
This study is trying to find out how genetics might affect hearing loss in people with Turner Syndrome to help develop new treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | Gødstrup Hospital Academic / other |
| Locations | 1 site (Herning) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | October 30, 2026 |
| Study ends | July 30, 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT06507007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 to 60 with Turner Syndrome who experience sensorineural hearing loss.
✕Probably not a fit
Patients with serious medical disorders, neurological or psychiatric conditions, or those taking medications affecting inner ear function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the genetic and epigenetic factors associated with sensorineural hearing loss in individuals with Turner Syndrome. By examining DNA methylation patterns and RNA expression profiles, the study seeks to identify potential links between these genetic markers and inner ear dysfunction. Participants will undergo a series of tests, including ear examinations, hearing assessments, balance evaluations, blood tests, and imaging scans, to gather comprehensive data on their inner ear health. The ultimate goal is to uncover insights that could lead to innovative treatments for hearing loss.
Why it matters
Potential benefit: If successful, this study could lead to new treatment options that may reduce or eliminate the need for hearing aids in patients with Turner Syndrome.
How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that exploring genetic and epigenetic factors can yield valuable insights into hearing loss.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 18 and 60 years old Exclusion Criteria: * Contraindications for the MRI or CBCT * Serious medical disorders * Neurological or psychiatric disorders of any kind * Use of medication that is known to influence inner ear function * Medical history with dizziness or hearing problems (controls only)
Where it's running
-
ENT department of Gødstrup Hospital
Herning, Denmark Recruiting
Study contacts
- Principal investigator: Therese Ovesen, Prof — University Clinic of Flavour, Balance and Sleep
- Study coordinator: Louise Hill-Madsen, MD
- Email: lohill@rm.dk
- Phone: 20282635
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers in Congenital Hearing Loss: Alpha-Tectorin, IL-10, and Thiol-Disulfide Balance in Children
This observational study tests whether levels of alpha-tectorin, IL-10, and thiol-disulfide balance differ in children with congenital sensorineural hearing loss (with cochlear implants or hearing aids) compared with healthy children.
-
Anatomy-based fitting for single-sided deaf CI users
This study tests whether anatomy-based fitting changes how well adults with single-sided deafness use a cochlear implant to understand speech in noise and to enjoy music.
-
Long-term outcomes of MED-EL SONATA 2 Cochlear Implants in real life
This study looks at long-term results from people who received a SONATA 2 cochlear implant to see how well it works in everyday life.
-
Anatomy-Based Fitting for People with a Cochlear Implant and Hearing Aid
This study tests whether an anatomy-based frequency distribution works better than the default one for adults with a cochlear implant and a contralateral hearing aid.
-
Biomarkers linked to congenital CMV using newborn blood spots
Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.
-
Inpegsomatropin vs Givopegsomatropin for short stature in girls with Turner syndrome
A 52-week, multicenter, randomized study tests whether Inpegsomatropin injections help prepubertal girls with Turner syndrome grow taller compared with a known treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.